Patents by Inventor Yun Qian

Yun Qian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090131671
    Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
    Type: Application
    Filed: October 24, 2008
    Publication date: May 21, 2009
    Inventors: Michael N. Greco, Harold R. Almond, JR., Lawrence de Garavilla, Michael J. Hawkins, Michael J. Humora, Yun Qian, Donald Gilmore Walker, Sergio Cesco-Cancian, Christopher Norman Nilsen, Mitul N. Patel, Kirk Leonard Sorgi, Eugene Powell
  • Publication number: 20090131371
    Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
    Type: Application
    Filed: October 24, 2008
    Publication date: May 21, 2009
    Inventors: Michael N. Greco, Harold R. Almond, JR., Lawrence de Garavilla, Michael J. Hawkins, Michael J. Humora, Yun Qian, Donald Gilmore Walker, Sergio Cesco-Cancian, Christopher Norman Nilsen, Mitul N. Patel, Kirk Leonard Sorgi, Eugene Powell
  • Publication number: 20090124581
    Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
    Type: Application
    Filed: October 24, 2008
    Publication date: May 14, 2009
    Inventors: Michael N. Greco, Harold R. Almond, JR., Lawrence de Garavilla, Michael J. Hawkins, Michael J. Humora, Yun Qian, Donald Gilmore Walker, Sergio Cesco-Cancian, Christopher Norman Nilsen, Mitul N. Patel, Kirk Leonard Sorgi, Eugene Powell
  • Publication number: 20090118504
    Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
    Type: Application
    Filed: October 24, 2008
    Publication date: May 7, 2009
    Inventors: Michael N. Greco, Harold R. Almond, JR., Lawrence de Garavilla, Michael J. Hawkins, Michael J. Humora, Yun Qian, Donald Gilmore Walker, Sergio Cesco-Cancian, Christopher Norman Nilsen, Mitul N. Patel, Kirk Leonard Sorgi, Eugene Powell
  • Publication number: 20090118235
    Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
    Type: Application
    Filed: October 24, 2008
    Publication date: May 7, 2009
    Inventors: Michael N. Greco, Harold R. Almond, JR., Lawrence de Garavilla, Michael J. Hawkins, Michael J. Humora, Yun Qian, Donald Gilmore Walker, Sergio Cesco-Cancian, Christopher Norman Nilsen, Mitul N. Patel, Kirk Leonard Sorgi, Eugene Powell
  • Publication number: 20090118508
    Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
    Type: Application
    Filed: October 24, 2008
    Publication date: May 7, 2009
    Inventors: Michael N. Greco, Harold R. Almond, JR., Lawrence Garavilla, Michael J. Hawkins, Michael J. Humora, Yun Qian, Donaid Gilmore Walker, Sergio Cesco-Cancian, Christopher Norman Nilsen, Mitul N. Patel, Kirk Leoperd Sorgi, Eugene Powell
  • Publication number: 20090118234
    Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
    Type: Application
    Filed: October 24, 2008
    Publication date: May 7, 2009
    Inventors: Michael N. Greco, Harold R. Almond, JR., Lawrene de Garavilla, Michael J. Hawkins, Michael J. Humora, Yun Qian, Donald Gilmore Walker, Sergio Cesco-Cancian, Christopher Norman Nilsen, Mitul N. Patel, Kirk Leonard Sorgi, Eugene Powell
  • Patent number: 7459461
    Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: December 2, 2008
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Michael N. Greco, Harold R. Almond, Lawrence de Garavilla, Michael J. Hawkins, Michael J. Humora, Yun Qian, Donald Gilmore Walker, Sergio Cesco-Cancian, Christopher Norman Nilsen, Mitul N. Patel, Kirk Leonard Sorgi, Eugene Powell
  • Publication number: 20080225468
    Abstract: An exemplary housing (100) for portable electronic device includes a main structure (10) and a static electricity eliminating structure (18). The main structure includes a top cover (12), a bottom cover (16) and a frame (14). The top cover faces the bottom cover. The frame is located between the top cover and bottom cover. The static electricity eliminating structure is in contact with the frame, which includes a main body (182) and a tin-cobalt alloy layer (184) formed on a surface of the main body.
    Type: Application
    Filed: August 17, 2007
    Publication date: September 18, 2008
    Applicants: HONG FU JIN PRECISION INDUSTRY (ShenZhen) CO., LTD., HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: WEI HUANG, RUI-KUN HUANG, YUN-QIAN WANG
  • Publication number: 20080021044
    Abstract: The present invention is directed to N-[2-[[(diaminomethylene)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-s-oxo-1(2H)-pyrazineacetamide, pharmaceutical compositions containing said compound and methods of treatment comprising inhibiting a serine protease using said compound. The present invention is further directed to a process for the preparation of the N-[2-[[(diaminomethylene)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxo-1(2H)-pyrazineacetamide as a free base. The present invention is further directed to a process for the preparation of pharmaceutically acceptable salts of N-[2-[[(aminoiminomethyl)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxo-1(2H)-pyrazineacetamide.
    Type: Application
    Filed: May 21, 2007
    Publication date: January 24, 2008
    Inventors: Mitul Patel, Christopher Nilsen, Mayra Reyes, Michael Humora, Yun Qian, Fuqiang Liu, Xini Zhang, Kirk Sorgi
  • Publication number: 20040082544
    Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
    Type: Application
    Filed: April 16, 2003
    Publication date: April 29, 2004
    Inventors: Michael N. Greco, Harold R. Almond, Lawrence de Garavilla, Michael J. Hawkins, Michael J. Humora, Yun Qian, Donald Gilmore Walker, Sergio Cesco-Cancian, Christopher Norman Nilsen, Mitul N. Patel, Kirk Leonard Sorgi, Eugene Powell
  • Publication number: 20030195172
    Abstract: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.
    Type: Application
    Filed: October 17, 2002
    Publication date: October 16, 2003
    Inventors: Michael N. Greco, Harold R. Almond, Lawrence de Garavilla, Michael J. Hawkins, Michael J. Humora, Yun Qian, Donald Gilmore Walker, Sergio Cesco-Cancian, Christopher Norman Nilsen, Mitul N. Patel
  • Patent number: 6175026
    Abstract: A metallocene corresponding to the formula wherein M is a group 4 transition metal, each Y is, independently, selected from the group of halogen, hydrocarbyl and hydrocarbyloxy, R1, R4 are, independently, selected from the group of hydrogen, hydrocarbyl, hydrocarbyloxy, R2, R3, R5, R6, R7, R8 are, independently, selected from the group of hydrogen, hydrocarbyl, hydrocarbyloxy, with the provision that, respectively, R2 and R3, R5 and R6, R7 and R8 can be linked to each other.
    Type: Grant
    Filed: April 6, 2000
    Date of Patent: January 16, 2001
    Assignee: Solvay Polyolefins Europe-Belgium
    Inventors: John J. Eisch, Yun Qian, J{umlaut over (u)}rgen Weber, Nicola Zandona, Fabian Siberdt
  • Patent number: 6087515
    Abstract: A metallocene corresponding to the formula ##STR1## wherein M is a group 4 transition metal, each Y is, independently, selected from the group of halogen, hydrocarbyl and hydrocarbyloxy,R.sup.1, R.sup.4 are, independently, selected from the group of hydrogen, hydrocarbyl, hydrocarbyloxy,R.sup.2, R.sup.3, R.sup.5, R.sup.6, R.sup.7, R.sup.8 are, independently, selected from the group of hydrogen, hydrocarbyl, hydrocarbyloxy, with the provision that, respectively, R.sup.2 and R.sup.3, R.sup.5 and R.sup.6, R.sup.7 and R.sup.8 can be linked to each other.A process for the preparation of metallocenes comprising the following steps:(a) contacting, in a solvent, a transition metal halide of formula MX.sub.4 with an organometallic compound of formula M'R.sub.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: July 11, 2000
    Assignee: Solvay Polyolefins Europe-Belgium (Societe Anonyme)
    Inventors: John J. Eisch, Yun Qian, Jurgen Weber, Nicola Zandona, Fabian Siberdt